Ensemble Health Partners, a healthcare revenue cycle management company, has postponed its planned initial public offering, citing adverse market conditions.
The company had been poised to come to market with an offering of shares at a range of $19 to $22 each.
"Given current market conditions, we have decided it is in our stakeholders' best interests to postpone our planned IPO," said Judson Ivy, Ensemble's founder and chief executive officer of Ensemble. "Ensemble is well-capitalized with significant organic and inorganic growth opportunities ahead. We are confident in our strategy and committed to delivering exceptional service to our clients as we continue on our mission of redefining the possible in healthcare."
Once Ensemble Health Partners goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.
It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Ensemble Health Partners stock.
See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
These are the stocks to buy when you don’t have much to spend.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
We review the Kalshi trading platform and explain how investors can use it as a hedge for their investments.
Market capitalization can help investors determine a company’s market value to predict growth, but there are some considerations to keep in mind.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Compare pros, cons, research tools and reviews for these two trading platforms.
Fractional shares are fractions of company shares. Sometimes they’re made by brokers to allow those with limited funds to get access to stocks.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.